Bruce Bloom and Aris Persidis to Chair 3rd Drug Repositioning, Repurposing and Rescue Conference

BOSTON - June 2, 2014 - PRLog -- The 3^rd Annual Drug Repositioning, Repurposing and Rescue Conference announces Bruce Bloom of Cures Within Reach and Aris Persidis of Biovista as conference chairs. The event will be held on July 15 & 16, 2014 at the Sheraton Commander hotel in Boston, MA. The focus of the conference is on explorations into new therapeutics entities; crowd funding and collaborative drug discovery and development.  Following is the conference agenda:

·      Why High Quality Phenotypic Screening is So Well Suited for Drug Repositioning - Andrew Reaume, Melior Discovery, Inc.

·      Social Investing to Support Rediscovery Research™ - Dr. Bruce Bloom, Cures Within Reach

·      The Challenges of Repositioning Drugs: 10 lessons From Black Bone Disease - Nicholas Sireau, AKU Society, Co-Founder, Findacure

·      The Drug Repurposing Patent Landscape: A Hotbed of Pharmaceutical Creativity  - Hermann Mucke, Ph.D., H.M. Pharma Consultancy

·      Prioritizing and Integrating Existing Methods into Cost-effective and Efficient Pipelines for Drug Repositioning - Stephen Wong, The Methodist Hospital Research Institute, Weill Cornell Medical College at Texas Medical Center

·      Comparison of Different Development Paths, Challenges and Profiles of Three Re-positioned Drug Products - Neal M. Farber, NeuroHealing Pharmaceuticals, Inc.

·      The NCATS Pharmaceutical Collection: Overview, Screening Processes, and Examples of Use in Cancer and Infectious Diseases - Anton Simeonov, National Center for Advancing Translational Sciences, National Institutes of Health

·      Drug Repurposing In Pediatrics: A Clinician's Perspective - Julie Blatt, University of North Carolina School of Medicine

·      Repositioning: Validating a Drug Target for a New Indication through Genetics, Expression, and Phenotypic Screening - Pankaj Agarwal, GlaxoSmithKline

·      Presentation by Mary E. Ogle, Teva Pharmaceuticals

·      Repurposing as a Viable, Risk-managed Business Model - Daniel Behr, Rediscovery Life Sciences

·      Integrating the Digital Universe of Information for Drug Discovery and Repurposing - Joel Dudley, Mount Sinai School of Medicine

·      Rethinking Design and Execution of Clinical Trials for Repositioned Drugs - Marc Foster, Transparency Life Sciences

·      Celgene Global Health:  Focusing on Those Who Can Least Afford to Live by Re-focusing a Proprietary Chemical Library - Jerome B. Zeldis, Celgene Global Health

·      Next Generation Repositioning: Taking the Serendipity Out - Aris Persidis, Biovista, Inc.

·      Development of a Topical Anti-inflammatory Compound Using Smart Re-Profiling - Dr. Robert Scoffin, Cresset, Co-Founder, Re-Pharm

·      Repositioning of Drugs for Renal Cell Cancer Using Transcriptome Signatures  - Towia Libermann, Beth Israel Deaconess Medical Center

·      Pushing the Boundaries of Science Together Through Open Innovation Partnerships - Craig D. Wegner, AstraZeneca Pharmaceuticals LP

For more information on this informative and exciting event please visit: www.drugrepositioningconference.com

Hilary Simonson

Arrowhead Publishers

866.945.0263 x702

Hilary.simonson@arrowheadpublishers.com